• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者移植后第一年贫血相关因素:一项横断面研究。

Factors associated with anaemia in kidney transplant recipients in the first year after transplantation: a cross-sectional study.

作者信息

Lim Andy K H, Kansal Arushi, Kanellis John

机构信息

Department of Nephrology, Monash Health, Clayton, Victoria, 3168, Australia.

Department of Medicine, Monash University, Clayton, Victoria, 3168, Australia.

出版信息

BMC Nephrol. 2018 Oct 5;19(1):252. doi: 10.1186/s12882-018-1054-7.

DOI:10.1186/s12882-018-1054-7
PMID:30290796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6173839/
Abstract

BACKGROUND

Anaemia after kidney transplantation may reduce quality of life, graft or patient survival. We aimed to determine the prevalence and risk factors for anaemia in the initial 12 months after transplantation.

METHODS

We conducted a cross-sectional study at 6 and 12 months after transplantation. Anaemia was defined by World Health Organization criteria taking into consideration erythropoietin use. Logistic regression was used to determine the association between demographic, clinical and pharmacological risk factors for the main outcome of moderate-severe anaemia.

RESULTS

A total of 336 transplant recipients were included and the prevalence of moderate-severe anaemia was 27.4% at 6 months and 15.2% at 12 months. Lower kidney function, female gender, transferrin saturation below 10% and proteinuria were associated with moderate-severe anaemia at both time points. Recent intravenous immunoglobulin treatment was associated with anaemia at 6 months. Recent infection and acute rejection were also associated with anaemia 12 months. Around 20% of patients had at least one blood transfusion but they were uncommon beyond 3 months.

CONCLUSIONS

Anaemia remains highly prevalent requiring treatment with erythropoietin and transfusions. Most identifiable risk factors relate to clinical problems rather than pharmacological management, while markers of iron-deficiency remain difficult to interpret in this setting.

摘要

背景

肾移植后贫血可能会降低生活质量、影响移植物或患者的存活。我们旨在确定移植后最初12个月内贫血的患病率及危险因素。

方法

我们在移植后6个月和12个月进行了一项横断面研究。根据世界卫生组织标准并考虑促红细胞生成素的使用情况来定义贫血。采用逻辑回归分析来确定人口统计学、临床和药理学危险因素与中重度贫血这一主要结局之间的关联。

结果

共纳入336例移植受者,中重度贫血的患病率在6个月时为27.4%,在12个月时为15.2%。在两个时间点,较低的肾功能、女性性别、转铁蛋白饱和度低于10%和蛋白尿均与中重度贫血相关。近期静脉注射免疫球蛋白治疗与6个月时的贫血相关。近期感染和急性排斥反应也与12个月时的贫血相关。约20%的患者至少接受过一次输血,但3个月后输血情况并不常见。

结论

贫血仍然非常普遍,需要用促红细胞生成素和输血进行治疗。大多数可识别的危险因素与临床问题而非药物治疗管理有关,而缺铁标志物在这种情况下仍难以解读。

相似文献

1
Factors associated with anaemia in kidney transplant recipients in the first year after transplantation: a cross-sectional study.肾移植受者移植后第一年贫血相关因素:一项横断面研究。
BMC Nephrol. 2018 Oct 5;19(1):252. doi: 10.1186/s12882-018-1054-7.
2
Post-transplantation anaemia in adult and paediatric renal allograft recipients-Guy's Hospital experience.成人及儿童肾移植受者的移植后贫血——盖伊医院的经验
Nephrol Dial Transplant. 2006 Jul;21(7):1974-80. doi: 10.1093/ndt/gfl121. Epub 2006 Apr 4.
3
Anemia and erythrocytosis in patients after kidney transplantation.肾移植患者的贫血和红细胞增多症。
Transpl Int. 2012 Oct;25(10):1013-23. doi: 10.1111/j.1432-2277.2012.01513.x. Epub 2012 Jun 21.
4
Anaemia after renal transplantation.肾移植后的贫血
Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V54-58. doi: 10.1093/ndt/gfh1057.
5
Anaemia after renal transplantation.肾移植后的贫血
Eur J Clin Invest. 2005 Dec;35 Suppl 3:89-94. doi: 10.1111/j.1365-2362.2005.01535.x.
6
Prevalence and predictors of blood transfusion after pediatric kidney transplantation.儿科肾移植后输血的流行情况和预测因素。
Pediatr Nephrol. 2018 Nov;33(11):2177-2184. doi: 10.1007/s00467-018-4017-0. Epub 2018 Jul 13.
7
Long-acting erythropoietin stimulating agents for persistent anemia after kidney transplant: risk factors and outcome.长效促红细胞生成素刺激剂用于肾移植后持续性贫血:危险因素及结局
Exp Clin Transplant. 2014 Jun;12(3):220-6.
8
Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.促红细胞生成素缺乏和相对抵抗会导致肾功能正常的肾移植受者出现贫血。
Nephrol Dial Transplant. 1996 Jan;11(1):177-81.
9
Treatment of Posttransplantation Anemia.移植后贫血的治疗
Contrib Nephrol. 2018;195:92-101. doi: 10.1159/000486939. Epub 2018 May 7.
10
A prospective protocol-based trial of darbepoetin alfa therapy to correct the early anemia following renal transplantation.一项基于方案的前瞻性试验,旨在使用达贝泊汀α治疗纠正肾移植后的早期贫血。
Transplant Proc. 2010 Nov;42(9):3537-41. doi: 10.1016/j.transproceed.2010.06.035.

引用本文的文献

1
Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge.肾移植术后的贫血与缺铁:一项尚未解决的挑战。
Clin Kidney J. 2025 Aug 19;18(9):sfaf252. doi: 10.1093/ckj/sfaf252. eCollection 2025 Sep.
2
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents.一项系统评价和荟萃分析,探讨导致肾移植后贫血的因素以及促红细胞生成素刺激剂的影响。
Syst Rev. 2024 Nov 12;13(1):278. doi: 10.1186/s13643-024-02709-8.
3
Risk factors and current state of therapy for anemia after kidney transplantation.

本文引用的文献

1
Renal and hematologic side effects of long-term intravenous immunoglobulin therapy in patients with neurologic disorders.长期静脉注射免疫球蛋白治疗神经系统疾病患者的肾脏和血液学副作用。
Muscle Nerve. 2017 Dec;56(6):1173-1176. doi: 10.1002/mus.25693. Epub 2017 May 30.
2
Posttransplant Anemia as a Prognostic Factor of Mortality in Kidney-Transplant Recipients.移植后贫血作为肾移植受者死亡率的一个预后因素
Biomed Res Int. 2017;2017:6987240. doi: 10.1155/2017/6987240. Epub 2017 Mar 19.
3
Anemia in nephrotic syndrome: approach to evaluation and treatment.
肾移植后贫血的危险因素及当前治疗状况
Front Med (Lausanne). 2024 Jan 8;10:1170100. doi: 10.3389/fmed.2023.1170100. eCollection 2023.
4
Blood transfusions post kidney transplantation are associated with inferior allograft and patient survival-it is time for rigorous patient blood management.肾移植后输血与移植肾及患者的较差生存率相关——是时候进行严格的患者血液管理了。
Front Nephrol. 2023 Jul 24;3:1236520. doi: 10.3389/fneph.2023.1236520. eCollection 2023.
5
Beneficial effect of roxadustat on early posttransplant anemia and iron utilization in kidney transplant recipients: a retrospective comparative cohort study.罗沙司他对肾移植受者移植后早期贫血和铁利用的有益作用:一项回顾性比较队列研究
Ann Transl Med. 2022 Dec;10(24):1360. doi: 10.21037/atm-22-5897.
6
Nutrition Disturbances and Metabolic Complications in Kidney Transplant Recipients: Etiology, Methods of Assessment and Prevention-A Review.肾移植受者的营养紊乱和代谢并发症:病因、评估方法和预防——综述。
Nutrients. 2022 Nov 24;14(23):4996. doi: 10.3390/nu14234996.
7
Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients.肾移植受者长期使用质子泵抑制剂与铁状态
J Clin Med. 2019 Sep 3;8(9):1382. doi: 10.3390/jcm8091382.
肾病综合征中的贫血:评估与治疗方法
Pediatr Nephrol. 2017 Aug;32(8):1323-1330. doi: 10.1007/s00467-016-3555-6. Epub 2016 Dec 21.
4
Clinical risk factors associated with the post-transplant anemia in kidney transplant patients.肾移植患者移植后贫血相关的临床危险因素。
Transpl Immunol. 2016 Sep;38:50-3. doi: 10.1016/j.trim.2016.07.006. Epub 2016 Jul 30.
5
Post-Transplant Anemia Has Strong Influences on Renal and Patient Outcomes in Living Kidney Transplant Patients.移植后贫血对活体肾移植患者的肾脏及患者预后有强烈影响。
Transplant Proc. 2016 Apr;48(3):878-83. doi: 10.1016/j.transproceed.2016.01.033.
6
Assessment of Anemia and Quality of Life in Patients With Renal Transplantation.
Transplant Proc. 2015 Dec;47(10):2875-80. doi: 10.1016/j.transproceed.2015.10.043.
7
Pre-Transplant Erythropoiesis-Stimulating Agent Hypo-Responsiveness and Post-Transplant Anemia.
Transplant Proc. 2015 Jul-Aug;47(6):1820-4. doi: 10.1016/j.transproceed.2015.06.012.
8
Post-renal transplantation anemia at 12 months: prevalence, risk factors, and impact on clinical outcomes.肾移植术后12个月时的贫血:患病率、危险因素及其对临床结局的影响。
Int Urol Nephrol. 2015 Sep;47(9):1577-85. doi: 10.1007/s11255-015-1069-y. Epub 2015 Aug 6.
9
Anemia has a negative impact on self-rated health in kidney transplant recipients with well-functioning grafts: findings from an 8-year follow-up study.贫血对移植肾功能良好的肾移植受者的自评健康有负面影响:一项8年随访研究的结果
Qual Life Res. 2016 Jan;25(1):183-92. doi: 10.1007/s11136-015-1067-7. Epub 2015 Jul 14.
10
Post-transplantation Anemia Predicts Cardiovascular Morbidity and Poor Graft Function in Kidney Transplant Recipients.移植后贫血可预测肾移植受者的心血管疾病发生率及移植肾功能不佳。
Transplant Proc. 2015 May;47(4):1178-81. doi: 10.1016/j.transproceed.2015.01.025.